Arrhythmia
Conditions
Keywords
Arrhythmia, syncope, antiarrhythmic
Brief summary
The purpose of this study is to learn the effects of a test drug on heart rhythm, and to provide additional data to see if the test drug is well tolerated and safe.
Interventions
Sponsors
Wyeth is now a wholly owned subsidiary of Pfizer
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
DOUBLE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients undergoing an electrophysiology study for evaluation of heart rhythm.
Exclusion criteria
* Patients with uncontrolled blood pressure * Patients with certain cardiac risk factors * Patients with significant kidney or liver problems
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This study takes place within 24 hours. The measure to determine the effect of the intervention will be the difference in values from the baseline electrophysiology study, and the values obtained after intervention within the test drug. | — |
Secondary
| Measure | Time frame |
|---|---|
| This study takes place within 24 hours, and looks at the changes in values of electrophysiology studies, before and after administration of test article. | — |
Countries
Canada, United States
Outcome results
None listed